Peter Widdess‐Walsh

ORCID: 0000-0003-4217-2575
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epilepsy research and treatment
  • Pharmacological Effects and Toxicity Studies
  • Genomics and Rare Diseases
  • Genetics and Neurodevelopmental Disorders
  • Neuroscience and Neuropharmacology Research
  • EEG and Brain-Computer Interfaces
  • Neurological disorders and treatments
  • Neonatal and fetal brain pathology
  • Metabolism and Genetic Disorders
  • Genomic variations and chromosomal abnormalities
  • Neurological and metabolic disorders
  • Psychosomatic Disorders and Their Treatments
  • Functional Brain Connectivity Studies
  • Infectious Encephalopathies and Encephalitis
  • Advanced MRI Techniques and Applications
  • Ion channel regulation and function
  • Schizophrenia research and treatment
  • Electrolyte and hormonal disorders
  • Fetal and Pediatric Neurological Disorders
  • Mitochondrial Function and Pathology
  • Glioma Diagnosis and Treatment
  • Autoimmune Neurological Disorders and Treatments
  • Neuroscience and Neural Engineering
  • Cardiovascular Syncope and Autonomic Disorders
  • Electrochemical Analysis and Applications

Beaumont Hospital
2017-2025

Botsford Hospital
2022-2025

Beaumont Hospital, Dearborn
2022-2025

Royal College of Surgeons in Ireland
2019-2024

Science Foundation Ireland
2024

Walter and Eliza Hall Institute of Medical Research
2021

The University of Adelaide
2021

Società Italiana di Reumatologia
2020

University of Luxembourg
2019

University of Tübingen
2019

Frontal lobe epilepsy (FLE) surgery is the second most common performed to treat pharmacoresistant epilepsy. Yet, little known about long-term seizure outcome following frontal lobectomy. The aim of this study investigate trends in longitudinal and identify potential prognostic indicators a cohort FLE patients investigated using modern diagnostic techniques. We reviewed 70 who underwent lobectomy between 1995 2003 (mean follow-up 4.1 +/- 3 years). Data were analysed survival analysis...

10.1093/brain/awl364 article EN Brain 2007-01-07
Andrew S. Allen Susannah T. Bellows Samuel F. Berkovic Joshua Bridgers Rosemary Burgess and 90 more Gianpiero L. Cavalleri Seo‐Kyung Chung Patrick Cossette Norman Delanty Dennis Dlugos Michael P. Epstein Catharine Freyer David B. Goldstein Erin L. Heinzen Michael S. Hildebrand Michael R. Johnson Ruben Kuzniecky Daniel H. Lowenstein Anthony G Marson Richard Mayeux Caroline M. Mebane Heather C. Mefford Terence J. O’Brien Ruth Ottman Steven Petrou Slavgé Petrovski William Owen Pickrell Annapurna Poduri Rodney A. Radtke Mark I. Rees Brigid M. Regan Zhong Ren Ingrid E. Scheffer Graeme J. Sills Rhys H. Thomas Quanli Wang Bassel Abou‐Khalil Brian K. Alldredge Dina Amrom Eva Andermann Frédérick Andermann Jocelyn F. Bautista Samuel F. Berkovic Judith Bluvstein Alex Boro Gregory D. Cascino D. Consalvo Patricia K. Crumrine Orrin Devinsky Dennis Dlugos Michael P. Epstein Miquel Fiol Nathan B. Fountain Jacqueline A. French Catharine Freyer Daniel J. Friedman Eric B. Geller Tracy A. Glauser Simon Glynn Kevin F. Haas Sheryl R. Haut Jean Hayward Sandra L. Helmers Sucheta M. Joshi Andrés M. Kanner Heidi E. Kirsch Robert C. Knowlton Eric H. Kossoff Rachel Kuperman Ruben Kuzniecky Daniel H. Lowenstein Paul Motika Edward J. Novotny Ruth Ottman Juliann Paolicchi Jack M. Parent Kristen Park Annapurna Poduri Lynette G. Sadleir Ingrid E. Scheffer Renée A. Shellhaas Elliott H. Sherr Jerry J. Shih Shlomo Shinnar Rani K. Singh Joseph Sirven Michael C. Smith Joseph Sullivan Liu Lin Thio Anu Venkat Eileen P.G. Vining Gretchen K. Von Allmen Judith Weisenberg Peter Widdess‐Walsh Melodie R. Winawer

10.1016/s1474-4422(16)30359-3 article EN The Lancet Neurology 2017-01-13

Abstract Objective Recent clinical trials have shown that cenobamate substantially improves seizure control in focal‐onset drug‐resistant epilepsy (DRE). However, little is known about cenobamate's performance highly active ( ≥ 20 seizures/month) and ultra‐refractory focal 6 failed treatments, including antiseizure medications [ASMs], surgery, vagus nerve stimulation). Here, we studied efficacy tolerability a “real‐world” severe DRE cohort. Methods We conducted single‐center retrospective...

10.1111/epi.17549 article EN cc-by-nc Epilepsia 2023-02-15

To assess short- and long-term seizure freedom, the authors reviewed 371 patients who underwent anterior temporal lobectomy to treat pharmacoresistant epilepsy. The mean follow-up duration was 5.5 years (range 1 14.1 years). Fifty-three percent of were free at 10 years. identified multiple predictors recurrence. Results EEG performed 6 months postoperatively correlated with occurrence severity recurrence, in addition breakthrough seizures discontinuation antiepileptic drugs.

10.1212/01.wnl.0000219810.71010.9b article EN Neurology 2006-06-26

Patients undergoing epilepsy surgery for focal cortical dysplasia (FCD) guided by subdural EEG generally have a poor surgical outcome. Our objective was to identify predictors of postoperative seizure recurrence in this patient cohort.We retrospectively reviewed 48 consecutive surgeries electrode recordings between 1990 and 2004 patients with pathologic diagnosis isolated FCD. Using survival analysis, we analyzed results the noninvasive evaluation, MRI, interictal ictal patterns, extent...

10.1212/01.wnl.0000267427.91987.21 article EN Neurology 2007-08-13

The contribution of somatic variants to epilepsy has recently been demonstrated, particularly in the etiology malformations cortical development. aim this study was determine diagnostic yield genes that have previously associated with a or germline model, ascertained from resected brain tissue patients multidrug-resistant focal epilepsy.

10.1111/epi.17943 article EN cc-by Epilepsia 2024-03-16

The aim of this study was to expand the spectrum epilepsy syndromes related STX1B, encoding presynaptic protein syntaxin-1B, and establish genotype-phenotype correlations by identifying further disease-related variants.We used next-generation sequencing in framework research projects diagnostic testing. Clinical data EEGs were reviewed, including already published cases. To estimate pathogenicity variants, we established newly developed silico prediction tools.We describe 17 new variants...

10.1212/wnl.0000000000007089 article EN cc-by Neurology 2019-02-09

Prodromal Phase of Idiopathic Generalized Epilepsy: A Register-Based Case Control Study. Gesche J, Rubboli G, Beier CP. Neurology 2024;103(8):e209921 Background and objectives: generalized epilepsy (IGE) is associated with distinct behavioral traits, symptoms frontal lobe dysfunction, psychiatric comorbidity. Whether are part the IGE endophenotype or secondary to burden chronic disease unknown. In this study, we aimed at describing sequence appearance in patients IGE. Methods: Inclusion...

10.1177/15357597251323127 article EN Epiliepsy currents/Epilepsy currents 2025-04-16

This article critiques the International League Against Epilepsy (ILAE) 2015-2017 classifications of epilepsy, epileptic seizures, and status epilepticus. It points out following shortcomings ILAE classifications: (1) they mix semiological terms with epileptogenic zone terminology; (2) simple widely accepted terminology has been replaced by complex containing less information; (3) seizure evolution cannot be described in any detail; (4) four-level epilepsy classification, level two (epilepsy...

10.1111/epi.14699 article EN Epilepsia 2019-03-28

To identify the causative gene in a large unsolved family with genetic epilepsy febrile seizures plus (GEFS+), we sequenced genomes of members, and then determined contribution identified to pathogenicity epilepsies by examining sequencing data from 2,772 additional patients.We performed whole genome 3 members GEFS+ family. Subsequently, exome 1,165 patients Epi4K dataset 1,329 Australian Epi25 were interrogated. Targeted resequencing was on 278 or phenotypes. Variants validated familial...

10.1212/wnl.0000000000011855 article EN Neurology 2021-03-23

Summary Purpose L ennox‐ G astaut syndrome ( LGS ) is a devastating childhood‐onset epilepsy syndrome. The cause unknown in 25% of cases. Little has been described about the specific clinical or electroencephalography EEG features genetic u ). E pilepsy P henome/ enome roject EPGP aims to characterize by phenotypic analysis patients with and their parents. Methods One hundred thirty‐five no known etiology parents were enrolled from 19 centers United States A ustralia. Clinical data medical...

10.1111/epi.12395 article EN Epilepsia 2013-10-07

Epilepsy and psychogenic nonepileptic seizures (PNES) can coexist may present in two forms: sequential simultaneous. In presentations, epileptic (ES) are treated PNES emerge later. Simultaneous recording of ES by video-electroencephalogram (vEEG) is less well described. We retrospectively reviewed all patients diagnosed with vEEG following standard seizure induction practices over a 21-month period. Within this cohort, we established the prevalence coexisting epilepsy using clinical...

10.1002/epi4.12071 article EN cc-by-nc-nd Epilepsia Open 2017-07-20
Coming Soon ...